Literature DB >> 533991

Residual marrow injury following cytotoxic drugs.

K J Trainor, R S Seshadri, A A Morley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 533991     DOI： 10.1016/0145-2126(79)90043-2

Source DB:  PubMed          Journal:  Leuk Res        ISSN： 0145-2126            Impact factor:   3.156


× No keyword cloud information.
  6 in total

1.  Further development of a model of chronic bone marrow aplasia in the busulphan-treated mouse.

Authors:  John A Turton; William R Sones; Charles M Andrews; Andrew M Pilling; Thomas C Williams; Gemma Molyneux; Sian Rizzo; Edward C Gordon-Smith; Frances M Gibson
Journal:  Int J Exp Pathol       Date:  2006-02       Impact factor: 1.925

2.  The haemotoxicity of mitomycin in a repeat dose study in the female CD-1 mouse.

Authors:  Gemma Molyneux; Frances M Gibson; Edward C Gordon-Smith; Andrew M Pilling; Kai Chiu Liu; Sian Rizzo; Susan Sulsh; John A Turton
Journal:  Int J Exp Pathol       Date:  2005-12       Impact factor: 1.925

3.  Haematopoietic late effects of prolonged bleomycin treatment in mice.

Authors:  M R Nowrousian; C G Schmidt
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

Review 4.  In vitro evidence of drug action in aplastic anemia.

Authors:  P C Vincent
Journal:  Blut       Date:  1984-07

5.  Drug-induced aplastic anaemia and agranulocytosis. Incidence and mechanisms.

Authors:  P C Vincent
Journal:  Drugs       Date:  1986-01       Impact factor: 9.546

6.  Serum FLT-3 ligand in a busulphan-induced model of chronic bone marrow hypoplasia in the female CD-1 mouse.

Authors:  Gemma Molyneux; Frances M Gibson; Matthew Whayman; John A Turton
Journal:  Int J Exp Pathol       Date:  2008-04       Impact factor: 1.925
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.